BENGALURU || Under the ‘Make in India’ initiative of prime minister Narendra Modi, an Indian company has successfully developed a critical ‘chemotherapy infusion set’ which will make treatment of cancer convenient and affordable in the country, its officials said.
Launching the first indigenously developed ‘set’ in Bangaluru, the management of the Mysuru-based Glowtronics Pvt Ltd along with Medikraft Services claimed it was a major advancement, as presently all chemotherapy devices are imported into India. Glowtronics is the first Company to launch this product, and the first unit to secure a License to manufacture it in India.
The ‘ Make in India ‘ event was held at Hotel Shangri-La, Bangalore attended by senior members of the Oncology fraternity. Dr Somashekhar, Prof & Chairman, Manipal Comprehensive Cancer Center presided over the event.
Dr Rajesh, Chief Anaethesist of HCG, Bangalore made the presentation of ‘ ERAS protocols in Onco-surgery, Dr Sachin Unit Head of Oncology, HCG, Bangalore BMT spoke about Nutrition Awareness during Onco-BMT therapy.
The event concluded with Manipal Hospital’s presentation of ‘ IMPACT of ERAS at Manipal Hospital which is the first Hospital in SE Asia to get the prestigious accreditation from the ERAS Society, Switzerland